Trintellix (vortioxetine) is a prescription antidepressant approved to treat major depressive disorder (MDD) in adults. It works differently from traditional SSRIs, acting on multiple serotonin targets at once, which gives it a distinct profile when it comes to cognitive effects, sexual side effects, and weight changes. It is not approved for use in children or adolescents.
How Trintellix Treats Depression
Trintellix belongs to a class sometimes called “multimodal” antidepressants because it doesn’t just do one thing. Traditional SSRIs block the serotonin transporter, the molecule that reabsorbs serotonin after it’s released. Trintellix does that too, but it also directly activates or blocks six different serotonin receptors. This combination increases the availability of serotonin along with norepinephrine and acetylcholine, a neurotransmitter involved in memory and attention.
In a meta-analysis of 11 clinical trials involving over 3,300 patients, Trintellix at 5, 10, and 20 mg per day significantly reduced depression scores compared to placebo. The effect was dose-dependent: patients on 20 mg saw the largest improvement, with depression rating scores dropping about 4.6 points more than placebo. The 10 mg dose showed a 3.6-point advantage. These are meaningful differences on a scale used to track depression severity over time.
Cognitive Benefits Beyond Mood
One of the features that sets Trintellix apart from other antidepressants is its effect on thinking and mental sharpness. Depression often causes problems with concentration, processing speed, and decision-making that can persist even after mood improves. Meta-analyses have found that Trintellix improves psychomotor speed (how quickly you can process and respond to information), executive control (planning and flexible thinking), and working memory. These cognitive benefits appear to be at least partially independent of its mood effects, meaning they aren’t simply a byproduct of feeling less depressed.
Dosing
The recommended starting dose is 10 mg once daily, taken with or without food. The target is typically 20 mg per day if tolerated. For people who find higher doses difficult, a 5 mg dose is available. Doses above 20 mg have not been studied in controlled trials.
Common Side Effects
Nausea is the most frequent side effect and the main reason people consider stopping. In clinical trials lasting 6 to 8 weeks, nausea, constipation, and vomiting occurred at least twice as often with Trintellix as with placebo. In a head-to-head study against escitalopram (Lexapro), 25% of Trintellix users reported nausea compared to about 5% on escitalopram. Headache (9.4%) and dizziness (8%) were also common. The nausea tends to improve over the first few weeks for most people.
Sexual Side Effects and Weight
Two side effects that drive many people to switch antidepressants are sexual dysfunction and weight gain. Trintellix performs relatively well on both counts. The Mayo Clinic lists vortioxetine among the antidepressants with the lowest rates of sexual side effects, in contrast to common SSRIs like sertraline (Zoloft), paroxetine (Paxil), and escitalopram (Lexapro), which are among the most likely to cause them.
On weight, clinical trials lasting up to six months showed no significant effect on body weight. Over a full year, the picture is more nuanced: about 11 to 13% of users experienced clinically significant weight gain, while roughly 8% lost weight. The average gain among those who did gain was modest, around 1.5 to 1.8 pounds. For people who have struggled with weight gain on other antidepressants, this profile is often a deciding factor.
Off-Label Uses
Although Trintellix is only FDA-approved for major depressive disorder, researchers have studied it for several other purposes. Early evidence suggests it may help with nerve pain in people who also have depression. In a three-month study, patients with both MDD and chronic nerve pain saw significant reductions in pain scores after starting Trintellix, with improvements beginning around the end of the first month. Animal studies have also shown promise for fibromyalgia-like pain and inflammatory pain, though human data is limited. Some clinicians have explored its potential for sleep modulation and restless legs syndrome based on its effects on dopamine and GABA signaling, but these uses remain preliminary.
Cost and Savings Programs
Trintellix does not have a generic version, so cost can be a real barrier. The list price is $540 for a 30-day supply. With commercial (private) insurance, the average out-of-pocket cost drops to about $59 per month. Medicare Part D beneficiaries pay roughly $40 per month on average, and Medicaid brings costs down to about $1.
For commercially insured patients, the manufacturer offers a savings card that can reduce the copay to as little as $10 per month, with savings up to $100 per 30-day fill and a $1,300 annual cap. This card is not available to anyone on a government-funded plan, including Medicare, Medicaid, TRICARE, or VA insurance. For uninsured patients or those with financial hardship, Takeda offers a separate patient assistance program called Help At Hand that provides the medication at no cost to qualifying individuals.